Annual CFI
-$17.64 M
-$26.98 M-288.69%
December 31, 2023
Summary
- As of February 8, 2025, LVTX annual cash flow from investing activities is -$17.64 million, with the most recent change of -$26.98 million (-288.69%) on December 31, 2023.
- During the last 3 years, LVTX annual CFI has fallen by -$17.13 million (-3412.95%).
- LVTX annual CFI is now -288.69% below its all-time high of $9.35 million, reached on December 31, 2022.
Performance
LVTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$447.00 K
+$108.00 K+31.86%
September 30, 2024
Summary
- As of February 8, 2025, LVTX quarterly cash flow from investing activities is $447.00 thousand, with the most recent change of +$108.00 thousand (+31.86%) on September 30, 2024.
- Over the past year, LVTX quarterly CFI has increased by +$17.30 million (+102.65%).
- LVTX quarterly CFI is now -94.18% below its all-time high of $7.68 million, reached on March 31, 2023.
Performance
LVTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$7.18 M
+$17.30 M+70.66%
September 30, 2024
Summary
- As of February 8, 2025, LVTX TTM cash flow from investing activities is -$7.18 million, with the most recent change of +$17.30 million (+70.66%) on September 30, 2024.
- Over the past year, LVTX TTM CFI has increased by +$5.90 million (+45.11%).
- LVTX TTM CFI is now -152.62% below its all-time high of $13.65 million, reached on March 31, 2023.
Performance
LVTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
LVTX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -288.7% | +102.7% | +45.1% |
| 3 y3 years | -3412.9% | +102.7% | +45.1% |
| 5 y5 years | -2126.6% | +102.7% | +45.1% |
LVTX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -288.7% | +59.5% | -94.2% | +102.7% | -152.6% | +83.5% |
| 5 y | 5-year | -288.7% | +59.5% | -94.2% | +101.0% | -152.6% | +83.5% |
| alltime | all time | -288.7% | +59.5% | -94.2% | +101.0% | -152.6% | +83.5% |
LAVA Therapeutics NV Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $447.00 K(+31.9%) | -$7.18 M(-70.7%) |
| Jun 2024 | - | $339.00 K(-52.8%) | -$24.48 M(-0.5%) |
| Mar 2024 | - | $718.00 K(-108.3%) | -$24.59 M(+39.5%) |
| Dec 2023 | -$17.64 M(-288.7%) | -$8.69 M(-48.4%) | -$17.64 M(+34.8%) |
| Sep 2023 | - | -$16.85 M(-7621.9%) | -$13.09 M(-226.5%) |
| Jun 2023 | - | $224.00 K(-97.1%) | $10.35 M(-24.2%) |
| Mar 2023 | - | $7.68 M(-285.5%) | $13.65 M(+46.1%) |
| Dec 2022 | $9.35 M | -$4.14 M(-162.9%) | $9.35 M(-26.2%) |
| Sep 2022 | - | $6.58 M(+86.4%) | $12.66 M(-134.7%) |
| Jun 2022 | - | $3.53 M(+4.7%) | -$36.47 M(-8.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $3.37 M(-510.6%) | -$40.01 M(-8.1%) |
| Dec 2021 | -$43.55 M(+8574.3%) | -$821.00 K(-98.1%) | -$43.55 M(+1.8%) |
| Sep 2021 | - | -$42.55 M(>+9900.0%) | -$42.78 M(+8223.4%) |
| Jun 2021 | - | -$8000.00(-95.2%) | -$514.00 K(-3.6%) |
| Mar 2021 | - | -$166.00 K(+185.2%) | -$533.40 K(+6.3%) |
| Dec 2020 | -$502.00 K(-36.6%) | -$58.20 K(-79.3%) | -$502.00 K(+13.1%) |
| Sep 2020 | - | -$281.80 K(+928.5%) | -$443.80 K(+174.0%) |
| Jun 2020 | - | -$27.40 K(-79.6%) | -$162.00 K(+20.4%) |
| Mar 2020 | - | -$134.60 K | -$134.60 K |
| Dec 2019 | -$792.00 K | - | - |
FAQ
- What is LAVA Therapeutics NV annual cash flow from investing activities?
- What is the all time high annual CFI for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual CFI year-on-year change?
- What is LAVA Therapeutics NV quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV quarterly CFI year-on-year change?
- What is LAVA Therapeutics NV TTM cash flow from investing activities?
- What is the all time high TTM CFI for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV TTM CFI year-on-year change?
What is LAVA Therapeutics NV annual cash flow from investing activities?
The current annual CFI of LVTX is -$17.64 M
What is the all time high annual CFI for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual cash flow from investing activities is $9.35 M
What is LAVA Therapeutics NV annual CFI year-on-year change?
Over the past year, LVTX annual cash flow from investing activities has changed by -$26.98 M (-288.69%)
What is LAVA Therapeutics NV quarterly cash flow from investing activities?
The current quarterly CFI of LVTX is $447.00 K
What is the all time high quarterly CFI for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly cash flow from investing activities is $7.68 M
What is LAVA Therapeutics NV quarterly CFI year-on-year change?
Over the past year, LVTX quarterly cash flow from investing activities has changed by +$17.30 M (+102.65%)
What is LAVA Therapeutics NV TTM cash flow from investing activities?
The current TTM CFI of LVTX is -$7.18 M
What is the all time high TTM CFI for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high TTM cash flow from investing activities is $13.65 M
What is LAVA Therapeutics NV TTM CFI year-on-year change?
Over the past year, LVTX TTM cash flow from investing activities has changed by +$5.90 M (+45.11%)